1-13 of 13
serum complement
Close
Sort by
Journal Articles

Mechanistic Evaluation of Efficacy Using Biomarkers of the Oral, Small Molecule Factor D Inhibitor, Danicopan (ACH-4471), in Untreated Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Antonio M. Risitano, MD PhD, Jong Wook Lee, MD PhD, Rosario Notaro, MD, Robert A. Brodsky, MD, Austin Kulasekararaj, MBBS MDMRCP FRCPath, Jaroslaw P. Maciejewski, MD PhD, Mingjun Huang, PhD, Michael Geffner, MD, Peter Browett, BMedSci, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2226.
https://doi.org/10.1182/blood-2019-124837
Published: 2019
Journal Articles

Serum Complement Levels in Immune Thrombocytopenia: Characterization and Relation to Clinical Features

Abraham Z Cheloff, MS, David J. Kuter, Hanny Al-Samkari, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1087.
https://doi.org/10.1182/blood-2019-125341
Published: 2019
Journal Articles

Response Rates, Non-Relapse Mortality, and Financial Implications of Transplant-Associated Thrombotic Microangiopathy Treated with Eculizumab

John L Vaughn, MD, Qiuhong Zhao, MS, Parvathi Ranganathan, PhD, Patrick Elder, Basem M. William, MRCP,MD, Marcin Puto, PharmD, Julianna Roddy, PharmD, Rebecca Klisovic, William Blum, MD, Don M Benson, Jr., MD PhD, Samantha M. Jaglowski, MDMPH, Alice S. Mims, MD MSCR, Jonathan E. Brammer, MD, Bhavana Bhatnagar, DO, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH, Leslie A Andritsos, MD, Sam Penza, MD, Allison R. Walker, MD MPH, Steven M. Devine, MD, Spero R Cataland, MD, Sumithira Vasu, MDMBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1932.
https://doi.org/10.1182/blood.V130.Suppl_1.1932.1932
Published: 2017
Journal Articles

Hemophagocytic Syndrome in Systemic Lupus Erythematosus : A Monocentric Review of 13 Cases

Zoubida Tazi Mezalek, professor, Wafaa Ammouri, Meriem Bourkia, Hicham Harmouche, Mouna Maamar, Mohammed Adnaoui
Journal: Blood
Blood (2016) 128 (22): 3687.
https://doi.org/10.1182/blood.V128.22.3687.3687
Published: 2016
Journal Articles

Antibody Engineering of Anti-TFPI Bypass Therapeutic BAY 1093884: Isotype Selection and Sequence Optimization

Pedro Paz, Jinger Xie, Fred Aswad
Journal: Blood
Blood (2015) 126 (23): 3496.
https://doi.org/10.1182/blood.V126.23.3496.3496
Published: 2015
Journal Articles

C5 Polymorphism in a Dutch Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH) and No Asian Ancestry, Resistant to Eculizumab, but in Vitro Sensitive to Coversin

Saskia Langemeijer, MD PhD, Jun-Ichi Nishimura, MD PhD, Wynne Weston-Davies, Miles A Nunn, DPhil, Yuzuru Kanakura, MD PhD, Ian J Mackie, Petra Muus, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1209.
https://doi.org/10.1182/blood.V126.23.1209.1209
Published: 2015
Journal Articles

Resistance to Complement Dependent Cytotoxicity in CLL Cells From Patients Treated with Ofatumumab

Nisar A. Baig, Ronald P. Taylor, PhD, Margaret A. Lindorfer, PhD, Amy K Church, Betsy R. LaPlant, Emily S. Pavey, Tait D. Shanafelt, MD, Timothy G. Call, MD, Neil Kay, MD, Grzegorz S. Nowakowski, MD, Clive S. Zent, MD
Journal: Blood
Blood (2011) 118 (21): 2836.
https://doi.org/10.1182/blood.V118.21.2836.2836
Published: 2011
Journal Articles

A Novel Splicing Mutation in NEMO Gene in a Patient with X-Linked Ectodermal Dysplasia with Immunodeficiency.

Syuhei Karakawa, MD, Satoshi Okada, MD, Miyuki Tsumura, MA, Yoko Mizoguchi, MD, Tomoki Kawai, MD, Ryota Nishikomori, MD, Shin'ichiro Yasunaga, MD, Yoshihiro Takihara, MD, Masao Kobayashi, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2665.
https://doi.org/10.1182/blood.V114.22.2665.2665
Published: 2009
Journal Articles

Enhanced Serum Complement Activation on Platelets Is Associated with Arterial Thrombosis in Patients with Systemic Lupus Erythematosus (SLE) and Antiphospholipid Antibodies(aPL).

Ellinor I.B. Peerschke, PhD, Wei Yin, Ph.D., Deborah R. Alpert, M.D., Ph.D., Jane E. Salmon, M.D., Robert A.S. Roubey, M.D., Berhane Ghebrehiwet, D.V.M., D.Sc.
Journal: Blood
Blood (2007) 110 (11): 1637.
https://doi.org/10.1182/blood.V110.11.1637.1637
Published: 2007
Journal Articles

Imatinib Mesylate Reduces Rituximab-Induced Tumor Growth Inhibition In Vivo on EBV-Associated Human B-Cell Lymphoma.

Fariba Némati, PhD, Claire Mathiot, MD, Isabelle Grandjean, PhD, Olivier Lantz, MD, PhD, Vincent Bordier, Sébastien Dewulf, Richard Ekue, James P. Di Santo, PhD, Marie-France Poupon, MD, PhD, Didier Decaudin, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2360.
https://doi.org/10.1182/blood.V110.11.2360.2360
Published: 2007
Journal Articles

Tumor Burden Related Immunodeficiency in Lymphoma Patients and Clinical Course.

Kathleen Jentsch-Ullrich, MD, Annegret Gerber, MD, Regina Reppin, MD, Michael Koenigsmann, MD, PhD, Martin Mohren, MD, Astrid Franke
Journal: Blood
Blood (2005) 106 (11): 4649.
https://doi.org/10.1182/blood.V106.11.4649.4649
Published: 2005
Journal Articles

Plasmapheresis as a Therapeutic Option for Castleman’s Disease [CD].

Maged Khalil, MD, Shetra Sivamurthy, MD.
Journal: Blood
Blood (2005) 106 (11): 4761.
https://doi.org/10.1182/blood.V106.11.4761.4761
Published: 2005
Journal Articles

Cellular Immunodeficiency in Untreated Lymphoma Patients.

Kathleen Jentsch-Ullrich, MD, Annegret Gerber, MD, Regina Reppin, MD, Michael Koenigsmann, MD, Martin Mohren, MD, Astrid Franke, MD
Journal: Blood
Blood (2004) 104 (11): 4555.
https://doi.org/10.1182/blood.V104.11.4555.4555
Published: 2004